Panel orders audit of stem cell program
By San Francisco Chronicle,
San Francisco Chronicle
| 03. 09. 2006
State lawmakers on Wednesday ordered an audit of the institute and committee created to spend $7 billion of voter-approved bonds aimed at funding stem cell research.
The Legislature's Joint Legislative Audit Committee voted unanimously to require the state auditor to review both the California Institute for Regenerative Medicine and the Independent Citizen's Oversight Committee. The stem cell program, approved by voters in November 2004, has come under fire for spending money on such things as public relations and lobbying and because many of the members of the oversight committee represent groups that may be awarded grants.
"I believe the audit will help ensure that the program is on sound footing as it moves into its grant-making phase next year,'' said state Sen. Deborah Ortiz, D-Sacramento, who called for the audit.
State Auditor Elaine Howle said the audit would evaluate the program's strategic plans and whether the two bodies are properly identifying and avoiding conflicts of interest. She also will look at whether the programs have the right controls in place to ensure they comply with state laws.
The audit will...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...